94 research outputs found
Preventing pain on injection of propofol: A comparison between lignocaine pre-treatment and lignocaine added to propofol
Publisher's copy made available with the permission of the publisherA randomized double-blind study compared two methods of preventing the pain from injection of propofol, lignocaine pre-treatment followed by propofol and lignocaine added to propofol. One hundred patients received a 4 ml solution intravenously with a venous tourniquet for 1 minute, followed by propofol mixed with 2 ml of solution. Patients were divided into two treatment groups of 50 patients each: 4 ml 1% lignocaine pre-treatment followed by propofol and 2 ml saline, or 4 ml saline followed by propofol and 2 ml 2% lignocaine. Pain was assessed with a 100 mm visual analogue scale after induction and in recovery. The incidence of injection pain was 8% in the propofol mixed with lignocaine group, and 28% in the lignocaine pre-treatment group. This difference is statistically significant (P=0.017). For those patients who had pain, the mean pain score was 26.5 on induction for the propofol with lignocaine group (n=4), while the mean score was 44.4 for the pre-treatment group (n=13). The difference was not statistically significant (P=0.25). None of the propofol mixed with lignocaine group recalled pain, while 13 of the pre-treatment group did so. Lignocaine pre-treatment does not improve the immediate or the recalled comfort of patients during propofol induction when compared to lignocaine added to propofol. It is recommended that lignocaine should be added to propofol for induction rather than given before induction.P. Lee, W. J. Russellhttp://www.aaic.net.au/Article.asp?D=200339
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study
Clinical practice guidelines recommend blockers of the renin-angiotensin system alone or in combination with other agents to reduce blood pressure and albuminuria in patients with type 2 diabetes. Dihydropyridine calcium channel blockers, however, may lower blood pressure but not albuminuria in these patients. Here we tested the hypothesis that combining an ACE inhibitor with either a thiazide diuretic or a calcium channel blocker will cause similar reductions in blood pressure and albuminuria in hypertensive type 2 diabetics. We conducted a double blind randomized controlled trial on 332 hypertensive, albuminuric type 2 diabetic patients treated with benazepril with either amlodipine or hydrochlorothiazide for 1 year. The trial employed a non-inferiority design. Both combinations significantly reduced the urinary albumin to creatinine ratio and sitting blood pressure of the entire cohort. The percentage of patients progressing to overt proteinuria was similar for both groups. When we examined patients who had only microalbuminuria and hypertension we found that a larger percentage of the diuretic and ACE inhibitor normalized their albuminuria. We conclude that initial treatment using benzaepril with a diuretic resulted in a greater reduction in albuminuria compared to the group of ACE inhibitor and calcium channel blocker. In contrast, blood pressure reduction, particularly the diastolic component, favored the combination with amilodipine. The dissociation between reductions in blood pressure and albuminuria may be related to factors other than blood pressure
Structure, Photophysics and the Order-Disorder Transition to the Beta Phase in Poly(9,9-(di -n,n-octyl)fluorene)
X-ray diffraction, UV-vis absorption and photoluminescence (PL) spectroscopy
have been used to study the well-known order-disorder transition (ODT) to the
beta phase in poly(9,9-(di n,n-octyl)fluorene)) (PF8) thin film samples through
combination of time-dependent and temperature-dependent measurements. The ODT
is well described by a simple Avrami picture of one-dimensional nucleation and
growth but crystallization, on cooling, proceeds only after molecular-level
conformational relaxation to the so called beta phase. Rapid thermal quenching
is employed for PF8 studies of pure alpha phase samples while extended
low-temperature annealing is used for improved beta phase formation. Low
temperature PL studies reveal sharp Franck-Condon type emission bands and, in
the beta phase, two distinguishable vibronic sub-bands with energies of
approximately 199 and 158 meV at 25 K. This improved molecular level structural
order leads to a more complete analysis of the higher-order vibronic bands. A
net Huang-Rhys coupling parameter of just under 0.7 is typically observed but
the relative contributions by the two distinguishable vibronic sub-bands
exhibit an anomalous temperature dependence. The PL studies also identify
strongly correlated behavior between the relative beta phase 0-0 PL peak
position and peak width. This relationship is modeled under the assumption that
emission represents excitons in thermodynamic equilibrium from states at the
bottom of a quasi-one-dimensional exciton band. The crystalline phase, as
observed in annealed thin-film samples, has scattering peaks which are
incompatible with a simple hexagonal packing of the PF8 chains.Comment: Submitted to PRB, 12 files; 1 tex, 1 bbl, 10 eps figure
Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE)
Background and purpose: The novel severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2), now named coronavirus disease 2019 (COVID-19), may change the risk of stroke through an enhanced systemic inflammatory response, hypercoagulable state, and endothelial damage in the cerebrovascular system. Moreover, due to the current pandemic, some countries have prioritized health resources towards COVID-19 management, making it more challenging to appropriately care for other potentially disabling and fatal diseases such as stroke. The aim of this study is to identify and describe changes in stroke epidemiological trends before, during, and after the COVID-19 pandemic. Methods: This is an international, multicenter, hospital-based study on stroke incidence and outcomes during the COVID-19 pandemic. We will describe patterns in stroke management, stroke hospitalization rate, and stroke severity, subtype (ischemic/hemorrhagic), and outcomes (including in-hospital mortality) in 2020 during COVID-19 pandemic, comparing them with the corresponding data from 2018 and 2019, and subsequently 2021. We will also use an interrupted time series (ITS) analysis to assess the change in stroke hospitalization rates before, during, and after COVID-19, in each participating center. Conclusion: The proposed study will potentially enable us to better understand the changes in stroke care protocols, differential hospitalization rate, and severity of stroke, as it pertains to the COVID-19 pandemic. Ultimately, this will help guide clinical-based policies surrounding COVID-19 and other similar global pandemics to ensure that management of cerebrovascular comorbidity is appropriately prioritized during the global crisis. It will also guide public health guidelines for at-risk populations to reduce risks of complications from such comorbidities. © 202
Complex nanostructured materials from segmented copolymers prepared by ATRP
The development of new controlled/living radical polymerization
processes, such as Atom Transfer Radical Polymerization (ATRP) and other
techniques such as nitroxide mediated polymerization and degenerative transfer
processes, including RAFT, opened the way to the use of radical polymerization
for the synthesis of well-defined, complex functional nanostructures. The
development of such nanostructures is primarily dependent on self-assembly of
well-defined segmented copolymers. This article describes the fundamentals of
ATRP, relevant to the synthesis of such systems. The self-assembly of block
copolymers prepared by ATRP is illustrated by three examples. In the first, block
copolymers of poly(butyl acrylate) with polyacrylonitrile phase separate, leading
to spherical, cylindrical or lamellar morphologies, depending on the block
copolymer composition. At a higher temperature, polyacrylonitrile block converts
to nanostructured carbon clusters, whereas poly(butyl acrylate) block serves as a
sacrificial block, aiding the development of designed nanostructures. In the
second example, conductive nanoribbons of poly(n-hexylthiophene) surrounded
by a matrix of organic polymers are formed from block copolymers prepared by
ATRP. The third example describes an inorganic-organic hybrid system consisting of
hard nanocolloidal silica particles (20 nm) grafted by
ATRP with well-defined polystyrene-poly(benzyl acrylate) block copolymer chains
(1000 chains per particle). Silica cores in this system are surrounded by
a rigid polystyrene inner shell and softer polyacrylate outer shell
- …